BioLife Solutions, Inc. (BLFS) Financials
BLFS Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 412.7 million | 75.1 million |
2023-09-30 | 411.2 million | 79.1 million |
2023-06-30 | 433.2 million | 81.0 million |
2023-03-31 | 446.5 million | 88.4 million |
BLFS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 1.3 million | 8.3 million |
2023-09-30 | -5.9 million | 9.1 million |
2023-06-30 | -8.3 million | 6.9 million |
2023-03-31 | -6.0 million | 7.4 million |
BLFS Net Income
No data available :(
BLFS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 51.7 million | - | 17.5 million |
2023-09-30 | 41.0 million | - | 18.2 million |
2023-06-30 | 48.1 million | - | 19.1 million |
2023-03-31 | 56.9 million | - | 18.3 million |
BLFS Shares Outstanding
BLFS Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 981000 | 4.4 million | 13.0 million | 4.5 million |
2023-09-30 | 1.5 million | 5.4 million | 12.5 million | 7.3 million |
2023-06-30 | 609000 | 4.8 million | 15.4 million | 6.3 million |
2023-03-31 | 3.3 million | 4.2 million | 14.8 million | 6.5 million |
BLFS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 32.7 million | 24.4 million |
2023-09-30 | 33.3 million | 21.7 million |
2023-06-30 | 39.5 million | 27.7 million |
2023-03-31 | 37.7 million | 23.7 million |
BLFS
Price: $17.53
52 week price:
Earnings Per Share: -1.52 USD
P/E Ratio: -7.87
Exchange: NCM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 447300
Ebitda: -233997Market Capitalization: 784.6 million